Journals / Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi / 2012 / Cilt: 25 - Sayı: 3

Alcohol craving, glutamate and acamprosate

Pages
189–197
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

EVREN, C. (2012). Alcohol craving, glutamate and acamprosate. Düşünen Adam - Psikiyatri ve Nörolojik Bilimler Dergisi, Cilt: 25 - Sayı: 3, 189–197. https://ajindex.com/articles/216580

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. U.S. Department of Health and Human Services. 10th Special report to the U.S. Congress on alcohol and health. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2000
  2. Swift RM. Drug therapy for alcohol dependence. N Engl J Med 1999; 340:1482-1490
  3. Finney JW, Hahn AC, Moos RH. The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects. Addiction 1996; 91:1773-1796
  4. Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W. The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. Eur Neuropsychopharmacol 2007; 17:558-566
  5. Bjorklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci 2007; 30:194-202
  6. Gass JT, Olive MF. Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 2008; 75:218-265
  7. Zieglgansberger W, Hauser C, Wetzel C, Putzke J, Siggins GR, Spanagel R. Actions of acamprosate on neurons of the central nervous system. In: Soyka M, editor. Acamprosate in relapse prevention of alcoholism. Berlin: Springer; 1996, 65-70
  8. De Witte P, Bachteler D, Spanagel R. Acamprosate: preclinical data. In: Spanagel R, Mann KF, editors. Drugs for relapse prevention of alcoholism. Basel, Switzerland: Birkha ̈user Verlag; 2005, 73-83
  9. De Witte P, Littleton J, Parot P, Koob G. Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs 2005; 19:517-537
  10. Harris BR, Prendergast MA, Gibson DA, Rogers DT, Blanchard JA, Holley RC, Fu MC, Hart SR, Pedigo NW, Littleton JM. Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD, suggesting a novel site of action at metabotropic glutamate receptors. Alcohol Clin Exp Res 2002; 26:1779-1793
  11. Dahchour A, De Witte P, Bolo N, Ne ́de ́lec JF, Muzet M, Durbin P, Macher JP. Central effects of acamprosate. Part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res 1998; 82:107-114
  12. Rossetti ZL, Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 1995; 283:177-183
  13. Gewiss M, Heidbreder C, Opsomer L, Durbin P, De Witte P. Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic i